ARISTINE CHENGHSIN-YUN SUNTsai, Yi-TzuYi-TzuTsaiLu, Po-LiangPo-LiangLuLee, Susan Shin-JungSusan Shin-JungLeeLee, Yi-TzuYi-TzuLeeWang, Yung-ChihYung-ChihWangLiu, Po-YuPo-YuLiuJUNG-YIEN CHIENPO-REN HSUEHChang, Shu-YuanShu-YuanChangUN-IN WUWANG-HUEI SHENGYEE-CHUN CHENSHAN-CHWEN CHANG2021-08-162021-08-162021-012312-0541https://scholars.lib.ntu.edu.tw/handle/123456789/578150Mycobacterium abscessus (MAB) has emerged as the predominant pulmonary non-tuberculous mycobacterial pathogen in parts of Asia, including Taiwan. The reasons for the significant increase in MAB infections in the non-cystic fibrosis (CF) populations are poorly understood. The study aimed to elucidate whether this increase is related to the spread of the globally successful clone of MAB.en[SDGs]SDG3Longitudinal non-cystic fibrosis trends of pulmonary Mycobacterium abscessus disease from 2010 to 2017: spread of the "globally successful clone" in Asiajournal article10.1183/23120541.00191-202033532483